A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors.

Alcohol-associated hepatitis (AH) is a critical global health issue characterized by acute liver inflammation and an elevated ...

IL-8+ neutrophils have been identified as key drivers of inflammation in severe alcohol-associated hepatitis (sAH). Targeting ...

Department of Homeland Security Investigations agent has been indicted in federal court for conspiring to sell synthetic ...

A new quick-and-easy nasal swab test for kids can diagnose the specific immune system drivers behind their asthma, ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

TNF inhibitors offered greater protection against fractures than NSAIDs in patients with axial spondyloarthritis (axSpA).

Study finds TNF inhibitors lower hip and spine fracture risk in axial spondyloarthritis, addressing inflammation-related ...

The global psoriasis biosimilars market is set to experience robust growth, with market value projected to rise from USD 9,228.6 million in 2024 to an impressive USD 26,679.9 million by 2034, ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...